Thirty-six percent of USPI’s 2022 case were musculoskeletal, followed by gastrointestinal cases, which made up 34 percent of the mix, according to a second-quarter report from Tenet.
During the second quarter of 2023, USPI saw growth in orthopedic volumes, Tenet CEO Saum Sutaria, MD, said in a July 31 earnings call, as transcribed by Seeking Alpha. Outpatient total joint replacement volume rose 12 percent year over year.
Dallas-based Tenet posted net income of $123 million in the second quarter of 2023.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
